Drug Profile
BB 006
Alternative Names: BB-006Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Bullet Biotechnology
- Class Cancer vaccines; Immunotherapies
- Mechanism of Action Immunostimulants; Toll-like receptor 9 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Solid-tumours in USA (Intratumoural, Injection)
- 05 Jul 2016 Early research in Solid tumours in USA (Intratumoural)